Progression analysis versus traditional methods to quantify slowing of disease progression in Alzheimer’s disease

Abstract Background The clinical meaningfulness of the effects of recently approved disease-modifying treatments (DMT) in Alzheimer’s disease is under debate. Available evidence is limited to short-term effects on clinical rating scales which may be difficult to interpret and have limited intrinsic...

Descripció completa

Dades bibliogràfiques

Autors principals:	Linus Jönsson, Milana Ivkovic, Alireza Atri, Ron Handels, Anders Gustavsson, Julie Hviid Hahn-Pedersen, Teresa León, Mathias Lilja, Jens Gundgaard, Lars Lau Raket
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2024-02-01
Col·lecció:	Alzheimer’s Research & Therapy
Matèries:	Alzheimer’s disease Disease progression Statistical model
Accés en línia:	https://doi.org/10.1186/s13195-024-01413-y
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!